EZH2 and breast cancer: However, Mittal’s group has performed the bioinformatics analysis of epigenetic-associated genes in breast cancer patients, which characterized overexpression of EZH2 catalytic function as a predominant carrier in TNBC metastasis with poor overall survival19.